Clinical Trial

Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer

Study acronym: ARMANI
Recruiting
View on ClinicalTrials.gov →
Summary
the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-12-16; most recent amendment 2024-06-12.
Status change: Not Yet Recruiting → Recruiting 2021-02-04
Trial Details
NCT Number NCT04678583
Lead Sponsor Technische Universität Dresden
Collaborators: German Cancer Research Center
Conditions Colorectal Liver Metastasis
Enrollment 240 participants
Start Date 2021-01-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-06-13